about
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits f...
Read More
51.92
0.23
(0.44%)
1.3M
XNAS Volume
XNAS 12 Nov, 2025 4:30 PM (EST)
High Financial Strength
Affordable Valuation
Technically Neutral
Strong Performer, Under Radar
These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns
View Similar
Embed DVM
Sanofi ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..